Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In-office Assessment of Voiding Function Following Botox Injection for Overactive Bladder; Does Measuring Post Void Residual Impact Management

NCT04155593 is registered in ClinicalTrials.gov with TriHealth Inc. as lead sponsor.

NCT NCT04155593
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04155593 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In-office Assessment of Voiding Function Following Botox Injection for Overactive Bladder; Does Measuring Post Void Residual Impact Management
Lead sponsor
TriHealth Inc.
Phase
Observational
Overall status
Completed
Start date
November 8, 2019
Completion date
July 15, 2020
Enrollment
135 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder